bendamustine hydrochloride

Italy

Drugs containing this active substance

  • BENDAMUSTINE ACCORD

    It is a cytotoxic drug used for the treatment of certain types of cancer, such as chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma.

    Form: powder and concentrate for solution for infusion

    Active substance Dosage
    bendamustine hydrochloride -

    ATC: L01AA09

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • BENDAMUSTINE EG

    It is used for the treatment of certain types of cancer, specifically: chronic lymphocytic leukemia (when fludarabine chemotherapy is not suitable), non-Hodgkin lymphomas that have not responded to rituximab, and multiple myeloma (when high-dose chemotherapy with stem cell transplant, thalidomide therapy, or bortezomib is not suitable).

    Form: powder and concentrate for solution for infusion

    Active substance Dosage
    bendamustine hydrochloride -

    ATC: L01AA09

    Manufacturer: EG S.P.A.

  • BENDAMUSTINE HIKMA

    This medicine is used for the treatment of certain types of cancer, such as chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma. It can be used alone or in combination with other drugs.

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    bendamustine hydrochloride -

    ATC: L01AA09

    Manufacturer: HIKMA FARMACEUTICA (PORTUGAL) S.A.

  • BENDAMUSTINE MEDAC

    This medicine is used for the treatment of certain types of cancer, specifically: chronic lymphocytic leukemia (when fludarabine chemotherapy is not suitable), non-Hodgkin lymphomas (that have not responded to rituximab or have had a short response), and multiple myeloma (when high-dose chemotherapy with stem cell transplant or thalidomide- or bortezomib-based therapies are not suitable).

    Form: powder and concentrate for solution for infusion

    Active substance Dosage
    bendamustine hydrochloride -

    ATC: L01AA09

    Manufacturer: MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH